共 7 条
[5]
Clinical applicability of B-type natriuretic peptide in patients with suspected heart failure in primary care in Spain: the PANAMA study[J] . Barrios,Llisterri,Escobar,Alfaro,Colado,Ridocci,Matali.Expert Review of Cardiovascular Therapy . 2011 (5)
[6]
Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure[J] . Satoshi Suzuki,Yasuchika Takeishi,Takeshi Niizeki,Yo Koyama,Tatsuro Kitahara,Toshiki Sasaki,Mina Sagara,Isao Kubota.American Heart Journal . 2008 (1)